Hospital
Phoenix Children's Hospital
Phoenix Children's Hospital was paid $555.71M by Medicaid between Jan 2018 and Dec 2024, across 770 billing codes. Its largest line is 99284, emergency room visit (serious) — 15% of everything it billed.
33Billing provider infoPHOENIX CHILDREN'S HOSPITAL
PHOENIX, AZ 85016
PHOENIX, AZ 85016
33aNPI1760480503assigned 07/13/2005
33bProvider typeChildren's Hospital
28Total paid$555.71M
24GClaims4,185,462
24DCodes billed770
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 511,331 | $66.32M | |
| 2019 | 588,830 | $78.12M | |
| 2020 | 475,934 | $60.23M | |
| 2021 | 596,739 | $79.52M | |
| 2022 | 656,659 | $87.88M | |
| 2023 | 675,521 | $89.60M | |
| 2024incomplete | 680,448 | $94.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 129,761 | 124,914 | $82.42M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 74,614 | 70,649 | $67.97M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 177,305 | 169,883 | $63.21M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 3.6% | 5,736 | 5,646 | $20.14M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 3.0% | 21,030 | 20,077 | $16.52M |
| 44970 | 2.6% | 2,524 | 2,467 | $14.35M | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.1% | 6,079 | 6,015 | $11.73M |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2.0% | 2,894 | 1,807 | $11.06M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.8% | 16,320 | 15,637 | $10.25M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.7% | 13,211 | 12,854 | $9.46M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1.6% | 1,604 | 1,525 | $9.02M |
| 54161 | 1.5% | 3,299 | 3,223 | $8.43M |
758 more codes
| 67311 | 1.5% | 2,828 | $8.30M | |
| 92587 | 1.3% | 18,047 | $7.47M | |
| G0378 | Hospital observation service, per hour | 1.3% | 41,028 | $7.18M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 44,927 | $7.06M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.2% | 5,954 | $6.74M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.2% | 5,277 | $6.56M |
| 80053 | Comprehensive metabolic panel | 1.1% | 91,852 | $6.21M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 1.1% | 13,736 | $6.11M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 2,709 | $5.37M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 2,798 | $5.34M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 50,967 | $4.77M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 6,097 | $4.60M |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 158,804 | $4.08M |
| 94060 | <1% | 10,826 | $4.01M | |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | <1% | 1,158 | $3.93M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 8,294 | $3.81M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 32,652 | $3.30M |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 17,678 | $3.30M |
| 92526 | <1% | 32,790 | $2.96M | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 32,921 | $2.94M |
| 95782 | <1% | 2,612 | $2.92M | |
| 54640 | <1% | 1,106 | $2.87M | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 30,441 | $2.81M |
| 20680 | <1% | 1,069 | $2.79M | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 93,523 | $2.64M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 14,437 | $2.59M |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 1,702 | $2.40M |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 5,262 | $2.21M |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 103,719 | $2.15M |
| 76770 | <1% | 17,430 | $2.13M | |
| 81229 | <1% | 2,018 | $1.98M | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 56,136 | $1.96M |
| 76825 | <1% | 2,243 | $1.95M | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 66,160 | $1.89M |
| 36430 | <1% | 5,818 | $1.89M | |
| 86902 | <1% | 4,501 | $1.78M | |
| 93975 | <1% | 3,810 | $1.67M | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 7,984 | $1.67M |
| 92611 | <1% | 6,726 | $1.64M | |
| 24538 | <1% | 210 | $1.63M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 3,404 | $1.61M |
| 31526 | <1% | 1,606 | $1.58M | |
| 90378 | <1% | 675 | $1.58M | |
| 94010 | <1% | 8,461 | $1.53M | |
| 95819 | <1% | 5,267 | $1.49M | |
| J3262 | Injection, tocilizumab, 1 mg | <1% | 858 | $1.39M |
| J0475 | Injection, baclofen, 10 mg | <1% | 1,267 | $1.38M |
| 92018 | <1% | 1,253 | $1.35M | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 49,958 | $1.25M |
| 54300 | <1% | 811 | $1.24M | |
| 87799 | <1% | 16,295 | $1.20M | |
| 42830 | <1% | 644 | $1.17M | |
| 73521 | <1% | 7,350 | $1.09M | |
| 72146 | <1% | 2,045 | $1.09M | |
| 72157 | <1% | 1,194 | $1.08M | |
| 70543 | <1% | 1,334 | $1.07M | |
| 99243 | <1% | 38,219 | $1.00M | |
| 25600 | <1% | 2,749 | $987K | |
| 87497 | <1% | 15,119 | $982K | |
| 74018 | <1% | 15,694 | $964K | |
| 74230 | <1% | 6,667 | $960K | |
| 72082 | <1% | 5,950 | $877K | |
| 96409 | <1% | 6,127 | $865K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 8,277 | $861K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 3,092 | $817K |
| 92523 | <1% | 6,912 | $792K | |
| 29075 | <1% | 2,477 | $787K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 37,321 | $786K |
| 73090 | <1% | 13,284 | $782K | |
| 96133 | <1% | 863 | $776K | |
| 77072 | <1% | 5,235 | $773K | |
| 93304 | <1% | 1,008 | $739K | |
| 95816 | <1% | 3,194 | $737K | |
| 43762 | <1% | 2,077 | $694K | |
| 92652 | <1% | 2,575 | $689K | |
| 72197 | <1% | 727 | $666K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 22,831 | $648K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 16,340 | $646K |
| 87507 | <1% | 2,619 | $643K | |
| 99245 | <1% | 15,804 | $640K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 41,970 | $637K |
| 95715 | <1% | 1,907 | $614K | |
| 74455 | <1% | 1,737 | $596K | |
| 30140 | <1% | 174 | $570K | |
| 92610 | <1% | 6,050 | $559K | |
| 73080 | <1% | 8,778 | $557K | |
| 74240 | <1% | 2,851 | $554K | |
| 73610 | <1% | 8,557 | $553K | |
| J0490 | Injection, belimumab, 10 mg | <1% | 117 | $545K |
| 29065 | <1% | 1,521 | $511K | |
| 88185 | <1% | 1,279 | $505K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 1,687 | $493K |
| 97162 | <1% | 6,042 | $485K | |
| 0225U | <1% | 4,234 | $480K | |
| 73100 | <1% | 5,427 | $475K | |
| B4088 | Gastrostomy/jejunostomy tube, low-profile, any material, any type, each | <1% | 2,671 | $471K |
| 72141 | <1% | 2,382 | $454K | |
| 73140 | <1% | 7,999 | $451K | |
| J0586 | Injection, abobotulinumtoxina, 5 units | <1% | 239 | $444K |
| 73590 | <1% | 7,639 | $444K | |
| J9070 | Cyclophosphamide, 100 mg | <1% | 501 | $437K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 3,177 | $433K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,714 | $424K |
| 54360 | <1% | 422 | $422K | |
| 97161 | <1% | 7,614 | $413K | |
| 73110 | <1% | 5,905 | $400K | |
| 73630 | <1% | 7,568 | $384K | |
| 37241 | <1% | 25 | $378K | |
| 80197 | <1% | 16,027 | $377K | |
| 42821 | <1% | 175 | $375K | |
| 77073 | <1% | 4,177 | $372K | |
| 96131 | <1% | 563 | $371K | |
| 97166 | <1% | 4,456 | $368K | |
| 94621 | <1% | 1,592 | $366K | |
| 73130 | <1% | 6,037 | $365K | |
| 95117 | <1% | 7,463 | $360K | |
| 93460 | <1% | 56 | $352K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 2,628 | $351K |
| 36512 | <1% | 625 | $344K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 8,157 | $340K |
| 31624 | <1% | 594 | $334K | |
| 76536 | <1% | 4,307 | $334K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 7,686 | $333K |
| 70486 | <1% | 2,169 | $332K | |
| 62322 | <1% | 4,244 | $324K | |
| 72081 | <1% | 2,935 | $312K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,706 | $310K |
| 95812 | <1% | 1,053 | $309K | |
| 93976 | <1% | 5,043 | $306K | |
| 92585 | <1% | 1,458 | $303K | |
| 97165 | <1% | 5,518 | $293K | |
| 24530 | <1% | 826 | $289K | |
| 90837 | Psychotherapy session, about an hour | <1% | 2,159 | $287K |
| 99205 | Prolong outpt/office vis | <1% | 6,745 | $281K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18,817 | $280K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 5,727 | $280K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 8,410 | $276K |
| 49500 | <1% | 69 | $273K | |
| 93308 | <1% | 670 | $270K | |
| 86920 | <1% | 4,641 | $267K | |
| 25605 | <1% | 552 | $266K | |
| 74183 | <1% | 733 | $265K | |
| 92579 | <1% | 8,673 | $254K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 4,284 | $252K |
| 88341 | <1% | 2,294 | $244K | |
| 73552 | <1% | 3,562 | $240K | |
| 73560 | <1% | 2,729 | $239K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 125,372 | $238K |
| 71555 | <1% | 201 | $237K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 20,621 | $237K |
| 49450 | <1% | 447 | $235K | |
| 67312 | <1% | 75 | $229K | |
| J2997 | Injection, alteplase recombinant, 1 mg | <1% | 1,652 | $219K |
| 94664 | <1% | 19,505 | $216K | |
| 26720 | <1% | 600 | $215K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 5,080 | $214K |
| 92588 | <1% | 518 | $209K | |
| 72170 | <1% | 2,293 | $208K | |
| 97116 | <1% | 9,025 | $207K | |
| 73562 | <1% | 4,601 | $202K | |
| 73564 | <1% | 987 | $201K | |
| 82728 | <1% | 14,262 | $201K | |
| 73000 | <1% | 3,372 | $201K | |
| 96450 | <1% | 2,956 | $194K | |
| 73070 | <1% | 2,485 | $194K | |
| C1769 | Guide wire | <1% | 5,339 | $191K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 25,104 | $185K |
| 49452 | <1% | 1,476 | $184K | |
| 29450 | <1% | 826 | $182K | |
| A4649 | Surgical supply; miscellaneous | <1% | 1,137 | $181K |
| 97750 | <1% | 681 | $169K | |
| 92557 | <1% | 1,605 | $168K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 15,713 | $167K |
| 94726 | <1% | 764 | $166K | |
| 77080 | <1% | 1,256 | $164K | |
| 36593 | <1% | 1,188 | $163K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,353 | $159K |
| 73620 | <1% | 1,213 | $156K | |
| 70491 | <1% | 605 | $155K | |
| P9035 | Platelets, pheresis, leukocytes reduced, each unit | <1% | 243 | $154K |
| 95700 | <1% | 1,406 | $153K | |
| 76885 | <1% | 1,687 | $152K | |
| J9312 | Injection, rituximab, 10 mg | <1% | 25 | $146K |
| 72156 | <1% | 1,149 | $146K | |
| 96156 | <1% | 1,933 | $144K | |
| 64450 | <1% | 878 | $142K | |
| 81268 | <1% | 310 | $138K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,767 | $135K |
| 64447 | <1% | 1,340 | $135K | |
| 99242 | <1% | 9,721 | $134K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 33,155 | $133K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 44 | $131K |
| 27750 | <1% | 381 | $130K | |
| 92650 | <1% | 888 | $128K | |
| 73060 | <1% | 2,410 | $128K | |
| 69210 | <1% | 461 | $125K | |
| 30802 | <1% | 122 | $121K | |
| 73030 | <1% | 2,226 | $121K | |
| 92582 | <1% | 3,366 | $120K | |
| 24640 | <1% | 504 | $120K | |
| J3490 | Unclassified drugs | <1% | 7,093 | $115K |
| 72100 | <1% | 2,080 | $113K | |
| 49591 | <1% | 42 | $111K | |
| 74270 | <1% | 383 | $109K | |
| 97760 | <1% | 1,317 | $108K | |
| 93971 | <1% | 1,171 | $108K | |
| 72158 | <1% | 1,346 | $108K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 814 | $107K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 2,174 | $106K |
| 29405 | <1% | 302 | $106K | |
| 94770 | <1% | 604 | $105K | |
| 51726 | <1% | 153 | $104K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | <1% | 221 | $103K |
| V5261 | Hearing aid, digital, binaural, bte | <1% | 212 | $102K |
| 76604 | <1% | 777 | $102K | |
| 78816 | <1% | 48 | $100K | |
| 36591 | <1% | 5,896 | $97K | |
| 76882 | <1% | 2,358 | $92K | |
| 10060 | <1% | 747 | $92K | |
| 17110 | <1% | 324 | $92K | |
| 47562 | <1% | 12 | $92K | |
| 86850 | <1% | 13,618 | $90K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 517 | $90K |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 245 | $89K |
| 62252 | <1% | 317 | $86K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,416 | $85K |
| 29085 | <1% | 344 | $82K | |
| 68815 | <1% | 38 | $79K | |
| 67808 | <1% | 40 | $78K | |
| 29888 | <1% | 38 | $77K | |
| 93225 | <1% | 870 | $73K | |
| 36590 | <1% | 104 | $72K | |
| 93531 | <1% | 13 | $72K | |
| 11900 | <1% | 323 | $71K | |
| 74712 | <1% | 216 | $70K | |
| 85046 | <1% | 5,935 | $69K | |
| 89230 | <1% | 1,811 | $69K | |
| 95951 | <1% | 53 | $65K | |
| 73660 | <1% | 1,350 | $64K | |
| 93505 | <1% | 126 | $63K | |
| 92552 | <1% | 2,439 | $62K | |
| 77075 | <1% | 1,417 | $62K | |
| 92602 | <1% | 351 | $61K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 7,057 | $61K |
| 86644 | <1% | 139 | $60K | |
| C8911 | Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium) | <1% | 125 | $59K |
| 74019 | <1% | 15,837 | $59K | |
| 92524 | <1% | 518 | $59K | |
| 99381 | <1% | 1,619 | $57K | |
| 83880 | <1% | 3,948 | $57K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,454 | $57K |
| 87040 | <1% | 17,444 | $56K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 634 | $55K |
| 67314 | <1% | 54 | $55K | |
| 96130 | <1% | 896 | $55K | |
| 70544 | <1% | 1,283 | $55K | |
| 92567 | <1% | 19,984 | $55K | |
| 29125 | <1% | 1,669 | $53K | |
| A9573 | Injection, gadopiclenol, 1 ml | <1% | 279 | $53K |
| T1002 | Rn services, up to 15 minutes | <1% | 892 | $52K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 371 | $52K |
| 64642 | <1% | 1,754 | $52K | |
| 97802 | <1% | 684 | $52K | |
| 26727 | <1% | 16 | $51K | |
| A9554 | Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries | <1% | 100 | $51K |
| 97803 | <1% | 913 | $50K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 334 | $49K |
| 76870 | <1% | 3,062 | $49K | |
| 93242 | <1% | 788 | $48K | |
| J1566 | Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg | <1% | 41 | $48K |
| 42975 | <1% | 222 | $47K | |
| 94729 | <1% | 657 | $46K | |
| 29105 | <1% | 2,373 | $45K | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 606 | $44K |
| 38220 | <1% | 364 | $43K | |
| 76937 | <1% | 2,235 | $43K | |
| 71250 | <1% | 303 | $43K | |
| 70360 | <1% | 818 | $42K | |
| 31541 | <1% | 25 | $42K | |
| 76800 | <1% | 333 | $40K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 428 | $40K |
| C1788 | Port, indwelling (implantable) | <1% | 1,216 | $40K |
| 97164 | <1% | 736 | $40K | |
| 87530 | <1% | 432 | $39K | |
| 97168 | <1% | 665 | $39K | |
| 69209 | <1% | 223 | $37K | |
| P9073 | Platelets, pheresis, pathogen-reduced, each unit | <1% | 41 | $37K |
| 73723 | <1% | 42 | $36K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 3,106 | $36K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 26,453 | $34K |
| 70480 | <1% | 190 | $34K | |
| 64415 | <1% | 314 | $34K | |
| 81025 | <1% | 36,677 | $34K | |
| 81267 | <1% | 470 | $33K | |
| 93296 | <1% | 750 | $32K | |
| 85055 | <1% | 1,264 | $32K | |
| 78708 | <1% | 40 | $31K | |
| 99383 | <1% | 698 | $31K | |
| 96113 | <1% | 142 | $30K | |
| 93356 | <1% | 2,226 | $30K | |
| 75561 | <1% | 71 | $30K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 27 | $30K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,096 | $29K |
| 85240 | <1% | 1,496 | $29K | |
| 29425 | <1% | 144 | $29K | |
| 12011 | <1% | 4,004 | $29K | |
| 75565 | <1% | 671 | $28K | |
| V5264 | Ear mold/insert, not disposable, any type | <1% | 2,462 | $27K |
| 97163 | <1% | 262 | $27K | |
| 88237 | <1% | 292 | $26K | |
| 95115 | <1% | 560 | $26K | |
| J1815 | Injection, insulin, per 5 units | <1% | 1,585 | $26K |
| 70250 | <1% | 1,577 | $25K | |
| 95180 | <1% | 69 | $24K | |
| 83021 | <1% | 1,640 | $24K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 24,869 | $24K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 185 | $23K |
| 27786 | <1% | 65 | $23K | |
| 68811 | <1% | 16 | $23K | |
| 73720 | <1% | 25 | $22K | |
| 87070 | <1% | 12,015 | $22K | |
| 96112 | <1% | 149 | $20K | |
| C1726 | Catheter, balloon dilatation, non-vascular | <1% | 102 | $20K |
| 97167 | <1% | 149 | $20K | |
| 29130 | <1% | 189 | $20K | |
| 31599 | <1% | 39 | $20K | |
| 80069 | <1% | 5,504 | $20K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 12,103 | $19K |
| 82784 | <1% | 9,288 | $19K | |
| 72040 | <1% | 612 | $19K | |
| 12001 | <1% | 3,034 | $18K | |
| 86356 | <1% | 70 | $18K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,910 | $18K |
| 90670 | <1% | 2,184 | $18K | |
| 96415 | <1% | 4,262 | $18K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 9,209 | $18K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 8,669 | $18K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 433 | $17K |
| 93280 | <1% | 505 | $17K | |
| 12002 | <1% | 544 | $17K | |
| 92651 | <1% | 31 | $17K | |
| 90686 | <1% | 3,038 | $17K | |
| 93325 | <1% | 25,571 | $17K | |
| 0002A | <1% | 179 | $17K | |
| 28470 | <1% | 61 | $17K | |
| 75557 | <1% | 159 | $16K | |
| 0001A | <1% | 203 | $16K | |
| 99382 | <1% | 371 | $16K | |
| 96376 | <1% | 8,426 | $16K | |
| 88342 | <1% | 5,245 | $16K | |
| 58300 | <1% | 114 | $16K | |
| 97763 | <1% | 228 | $16K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 193 | $15K |
| 26600 | <1% | 43 | $15K | |
| 81403 | <1% | 86 | $15K | |
| 96139 | <1% | 66 | $15K | |
| 85610 | <1% | 16,074 | $15K | |
| 86921 | <1% | 1,654 | $15K | |
| 92586 | <1% | 41 | $14K | |
| 83970 | <1% | 1,315 | $13K | |
| 86703 | <1% | 933 | $13K | |
| 31720 | <1% | 3,173 | $13K | |
| 92593 | <1% | 424 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 41,576 | $12K |
| 25565 | <1% | 32 | $12K | |
| 36000 | <1% | 17,621 | $12K | |
| 76942 | <1% | 1,237 | $12K | |
| 97542 | <1% | 747 | $12K | |
| 86360 | <1% | 1,514 | $11K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $11K |
| 83020 | <1% | 367 | $11K | |
| 96411 | <1% | 3,189 | $11K | |
| 0071A | <1% | 89 | $11K | |
| 0072A | <1% | 81 | $11K | |
| 99384 | <1% | 210 | $11K | |
| V5010 | Assessment for hearing aid | <1% | 150 | $11K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,078 | $10K |
| 22899 | <1% | 40 | $10K | |
| 87186 | <1% | 11,151 | $10K | |
| 92553 | <1% | 245 | $10K | |
| 36592 | <1% | 2,801 | $10K | |
| 64640 | <1% | 49 | $10K | |
| 25560 | <1% | 26 | $10K | |
| 92595 | <1% | 523 | $9K | |
| 86900 | <1% | 14,315 | $9K | |
| 70555 | <1% | 19 | $9K | |
| 96167 | <1% | 170 | $9K | |
| 64643 | <1% | 1,722 | $9K | |
| 85730 | <1% | 13,604 | $9K | |
| 96132 | <1% | 869 | $9K | |
| 73700 | <1% | 67 | $9K | |
| 86832 | <1% | 24 | $8K | |
| 85250 | <1% | 233 | $8K | |
| 92604 | <1% | 51 | $8K | |
| J0834 | Injection, cosyntropin, 0.25 mg | <1% | 64 | $8K |
| C1729 | Catheter, drainage | <1% | 70 | $8K |
| 80195 | <1% | 3,915 | $8K | |
| 62270 | <1% | 367 | $8K | |
| 74181 | <1% | 26 | $8K | |
| V5011 | Fitting/orientation/checking of hearing aid | <1% | 1,366 | $7K |
| 51600 | <1% | 1,698 | $7K | |
| 43760 | <1% | 161 | $7K | |
| 72070 | <1% | 841 | $7K | |
| 31575 | <1% | 12 | $7K | |
| 78725 | <1% | 109 | $7K | |
| 29345 | <1% | 26 | $7K | |
| 86635 | <1% | 862 | $7K | |
| 82803 | <1% | 6,414 | $7K | |
| 76857 | <1% | 228 | $7K | |
| 95990 | <1% | 500 | $7K | |
| 92522 | <1% | 64 | $7K | |
| 73220 | <1% | 17 | $6K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 56,325 | $6K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 3,484 | $6K |
| 91122 | <1% | 43 | $6K | |
| 76506 | <1% | 38 | $6K | |
| 99195 | <1% | 124 | $6K | |
| 96158 | <1% | 56 | $6K | |
| 0450 | Emergency room services | <1% | 148 | $6K |
| 78264 | <1% | 13 | $6K | |
| 93270 | <1% | 392 | $5K | |
| 82140 | <1% | 186 | $5K | |
| 82533 | <1% | 844 | $5K | |
| 94375 | <1% | 13 | $5K | |
| 87102 | <1% | 1,266 | $5K | |
| 29505 | <1% | 629 | $5K | |
| 55175 | <1% | 12 | $5K | |
| 92550 | <1% | 821 | $5K | |
| V5257 | Hearing aid, digital, monaural, bte | <1% | 12 | $5K |
| 54150 | <1% | 180 | $5K | |
| 27824 | <1% | 12 | $5K | |
| 76377 | <1% | 331 | $4K | |
| 24650 | <1% | 13 | $4K | |
| 11981 | <1% | 48 | $4K | |
| 81243 | <1% | 1,408 | $4K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 1,090 | $4K |
| 96137 | <1% | 1,293 | $4K | |
| 85379 | <1% | 1,650 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 4,836 | $4K |
| 80061 | Lipid panel | <1% | 3,666 | $4K |
| 93227 | <1% | 248 | $4K | |
| V5267 | Hearing aid or assistive listening device/supplies/accessories, not otherwise specified | <1% | 40 | $4K |
| 29086 | <1% | 12 | $4K | |
| 85670 | <1% | 2,806 | $4K | |
| 57410 | <1% | 15 | $3K | |
| 87081 | <1% | 11,962 | $3K | |
| 90685 | <1% | 250 | $3K | |
| 82657 | <1% | 3,447 | $3K | |
| S9441 | Asthma education, non-physician provider, per session | <1% | 109 | $3K |
| 76376 | <1% | 8,314 | $3K | |
| 85576 | <1% | 382 | $3K | |
| 92626 | <1% | 15 | $3K | |
| 50200 | <1% | 13 | $3K | |
| 45331 | <1% | 147 | $3K | |
| 96040 | <1% | 4,029 | $3K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 19,103 | $3K |
| 81001 | <1% | 72,633 | $3K | |
| 91040 | <1% | 83 | $3K | |
| 97533 | <1% | 131 | $3K | |
| 93229 | <1% | 14 | $2K | |
| 51701 | <1% | 110 | $2K | |
| 72020 | <1% | 12 | $2K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 265 | $2K |
| 88312 | <1% | 426 | $2K | |
| 96900 | <1% | 51 | $2K | |
| 83516 | <1% | 1,011 | $2K | |
| B4087 | Gastrostomy/jejunostomy tube, standard, any material, any type, each | <1% | 28 | $2K |
| 96523 | <1% | 56 | $2K | |
| 72202 | <1% | 12 | $2K | |
| 82105 | <1% | 786 | $2K | |
| A9562 | Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | <1% | 43 | $2K |
| 86880 | <1% | 1,928 | $2K | |
| 85097 | <1% | 828 | $2K | |
| 81003 | <1% | 13,828 | $2K | |
| 62370 | <1% | 118 | $2K | |
| 72195 | <1% | 15 | $2K | |
| 75573 | <1% | 12 | $2K | |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | <1% | 83 | $2K |
| 76010 | <1% | 2,121 | $2K | |
| 20610 | <1% | 14 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,379 | $2K |
| 94762 | <1% | 4,005 | $2K | |
| 20611 | <1% | 32 | $2K | |
| 82248 | <1% | 14,131 | $2K | |
| J7342 | Instillation, ciprofloxacin otic suspension, 6 mg | <1% | 426 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 16,875 | $1K |
| 86359 | <1% | 65 | $1K | |
| 0353U | <1% | 578 | $1K | |
| 95886 | <1% | 75 | $1K | |
| 82272 | <1% | 1,919 | $1K | |
| P9011 | Blood, split unit | <1% | 70 | $1K |
| 72080 | <1% | 30 | $1K | |
| 0112A | <1% | 12 | $1K | |
| J2704 | Injection, propofol, 10 mg | <1% | 46,823 | $1K |
| J3535 | Drug administered through a metered dose inhaler | <1% | 60 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 89,800 | $1K |
| 96116 | <1% | 732 | $1K | |
| 70481 | <1% | 57 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 20 | $1K |
| 0003A | <1% | 12 | $1K | |
| 85384 | <1% | 2,902 | $1K | |
| 88184 | <1% | 1,487 | $1K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 25,314 | $1K |
| 84439 | <1% | 6,254 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,213 | $1K |
| 85652 | <1% | 10,734 | $1K | |
| 90688 | <1% | 39 | $1K | |
| 0115U | <1% | 103 | $1K | |
| 92591 | <1% | 12 | $1K | |
| 80074 | <1% | 59 | $1K | |
| 92555 | <1% | 2,074 | $1K | |
| 88108 | <1% | 4,226 | $1K | |
| 86945 | <1% | 3,839 | $1K | |
| 83520 | <1% | 49 | $1K | |
| 88307 | <1% | 1,120 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 217 | $1K |
| 95012 | <1% | 3,035 | $1K | |
| 70460 | <1% | 24 | $1K | |
| 99417 | Prolong home eval add 15m | <1% | 452 | $1K |
| 94644 | <1% | 2,255 | $1K | |
| 87400 | <1% | 2,441 | $957.92 | |
| 92592 | <1% | 106 | $948.94 | |
| 82570 | <1% | 8,846 | $909.14 | |
| 90734 | <1% | 36 | $825.03 | |
| 76827 | <1% | 2,245 | $820.95 | |
| 88313 | <1% | 1,590 | $807.43 | |
| 84145 | <1% | 10,789 | $776.08 | |
| 88348 | <1% | 38 | $769.38 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | <1% | 8,758 | $765.64 |
| 95873 | <1% | 1,165 | $763.99 | |
| 83735 | <1% | 38,891 | $755.65 | |
| 89051 | <1% | 5,308 | $747.13 | |
| 90620 | <1% | 12 | $746.18 | |
| 64425 | <1% | 24 | $744.64 | |
| 96125 | <1% | 16 | $714.46 | |
| 29515 | <1% | 241 | $693.19 | |
| 88264 | <1% | 289 | $629.75 | |
| 82962 | <1% | 21,759 | $626.75 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 5,632 | $626.60 |
| 76981 | <1% | 1,961 | $603.51 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 7,191 | $593.66 |
| 83690 | <1% | 11,944 | $591.17 | |
| 73200 | <1% | 16 | $574.77 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 3,003 | $566.02 |
| 84703 | <1% | 897 | $558.26 | |
| 84100 | <1% | 29,346 | $556.77 | |
| 93321 | <1% | 1,991 | $553.37 | |
| 86140 | <1% | 19,518 | $545.13 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,194 | $528.90 |
| 96168 | <1% | 85 | $528.28 | |
| 80076 | <1% | 51 | $510.73 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 49,960 | $507.04 |
| 86922 | <1% | 1,664 | $506.06 | |
| 93299 | <1% | 12 | $488.20 | |
| 84484 | <1% | 688 | $487.56 | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | <1% | 243 | $473.40 |
| 86352 | <1% | 111 | $468.59 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,221 | $457.55 |
| 82139 | <1% | 55 | $449.95 | |
| 87449 | <1% | 101 | $443.40 | |
| 92556 | <1% | 2,262 | $442.74 | |
| 90656 | <1% | 67 | $431.13 | |
| 87486 | <1% | 4,118 | $418.43 | |
| 87581 | <1% | 4,120 | $408.29 | |
| 86901 | <1% | 14,315 | $403.03 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 12,470 | $398.56 |
| 87077 | <1% | 14,050 | $380.12 | |
| 76776 | <1% | 15 | $363.71 | |
| 86833 | <1% | 12 | $361.16 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 1,787 | $354.60 |
| 84702 | <1% | 167 | $352.20 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 28,765 | $350.32 |
| 83605 | <1% | 6,891 | $337.66 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 9,608 | $334.52 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 47,882 | $332.70 |
| 99360 | <1% | 470 | $326.22 | |
| 76642 | <1% | 12 | $321.51 | |
| 93320 | <1% | 21,100 | $318.08 | |
| 82565 | <1% | 3,138 | $312.61 | |
| 96136 | <1% | 1,296 | $307.28 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 31,600 | $285.97 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 38,645 | $282.25 |
| 85027 | <1% | 3,679 | $279.07 | |
| 36416 | <1% | 1,598 | $256.10 | |
| 82550 | <1% | 5,250 | $255.43 | |
| 88304 | <1% | 5,393 | $252.91 | |
| 86357 | <1% | 1,550 | $242.78 | |
| 99152 | <1% | 1,082 | $233.25 | |
| 82330 | <1% | 4,441 | $224.19 | |
| 83540 | <1% | 8,880 | $217.01 | |
| 83615 | <1% | 6,755 | $209.92 | |
| C1766 | Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away | <1% | 259 | $206.25 |
| 72072 | <1% | 15 | $204.29 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 1,940 | $202.21 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 384 | $200.26 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,807 | $183.08 |
| 86923 | <1% | 1,849 | $182.07 | |
| 82150 | <1% | 3,956 | $180.95 | |
| 82977 | <1% | 6,961 | $178.91 | |
| 87533 | <1% | 2,363 | $166.98 | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | <1% | 2,622 | $164.32 |
| 85018 | <1% | 3,484 | $147.14 | |
| 87205 | <1% | 6,898 | $138.70 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 2,844 | $132.08 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 15,282 | $127.38 |
| 82043 | <1% | 50 | $126.13 | |
| 86706 | <1% | 453 | $120.84 | |
| S9443 | Lactation classes, non-physician provider, per session | <1% | 463 | $119.04 |
| 90633 | <1% | 14 | $118.60 | |
| 86665 | <1% | 217 | $115.87 | |
| 88300 | <1% | 6,556 | $108.87 | |
| 85045 | <1% | 13,044 | $95.61 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,636 | $94.57 |
| 92594 | <1% | 39 | $93.26 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 11,738 | $91.25 |
| 86803 | <1% | 424 | $90.95 | |
| 90744 | <1% | 1,125 | $86.37 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,752 | $86.04 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,029 | $81.84 |
| 96367 | <1% | 2,629 | $78.74 | |
| A7521 | Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each | <1% | 65 | $78.44 |
| 51702 | <1% | 27 | $71.75 | |
| 86171 | <1% | 13 | $68.82 | |
| 84156 | <1% | 8,499 | $63.79 | |
| 87210 | <1% | 1,270 | $60.31 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 338 | $59.96 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 2,422 | $59.73 |
| 84550 | <1% | 1,838 | $59.30 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,001 | $56.39 |
| 85660 | <1% | 3,163 | $54.54 | |
| 30300 | <1% | 172 | $51.36 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 781 | $47.49 |
| 93272 | <1% | 28 | $45.84 | |
| 87340 | <1% | 318 | $45.22 | |
| J3410 | Injection, hydroxyzine hcl, up to 25 mg | <1% | 164 | $44.29 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 10,644 | $44.01 |
| 86308 | <1% | 983 | $37.17 | |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | <1% | 715 | $31.92 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 5,042 | $30.33 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 2,673 | $30.05 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 2,186 | $29.34 |
| 83550 | <1% | 8,810 | $27.55 | |
| 82310 | <1% | 318 | $22.13 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 504 | $20.40 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 1,041 | $18.95 |
| 85014 | <1% | 1,128 | $18.65 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,572 | $18.19 |
| 86038 | <1% | 446 | $18.12 | |
| 94645 | <1% | 614 | $13.53 | |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | <1% | 1,009 | $13.05 |
| 84295 | <1% | 411 | $9.27 | |
| 82945 | <1% | 578 | $8.13 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 946 | $5.91 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 733 | $5.83 |
| 82247 | <1% | 734 | $5.57 | |
| 84132 | <1% | 303 | $4.25 | |
| 82435 | <1% | 242 | $4.10 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 935 | $2.98 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,091 | $0.18 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 1,319 | $0.16 |
| 84630 | 0% | 69 | $0.00 | |
| 82785 | 0% | 102 | $0.00 | |
| 87150 | 0% | 85 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 52 | $0.00 |
| A7520 | Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each | 0% | 59 | $0.00 |
| 87045 | 0% | 91 | $0.00 | |
| 88344 | 0% | 114 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 207 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 35 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 1,075 | $0.00 |
| 82652 | 0% | 111 | $0.00 | |
| S0028 | Injection, famotidine, 20 mg | 0% | 158 | $0.00 |
| G0168 | Wound closure utilizing tissue adhesive(s) only | 0% | 186 | $0.00 |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 0% | 60 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 396 | $0.00 |
| 88188 | 0% | 13 | $0.00 | |
| 86480 | 0% | 17 | $0.00 | |
| 86645 | 0% | 118 | $0.00 | |
| 84305 | 0% | 12 | $0.00 | |
| 87252 | 0% | 18 | $0.00 | |
| 93568 | 0% | 96 | $0.00 | |
| 93567 | 0% | 52 | $0.00 | |
| 90715 | 0% | 27 | $0.00 | |
| 86039 | 0% | 107 | $0.00 | |
| 87324 | 0% | 13 | $0.00 | |
| 75827 | 0% | 35 | $0.00 | |
| 96138 | 0% | 67 | $0.00 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 28 | $0.00 |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 0% | 12 | $0.00 |
| 86663 | 0% | 27 | $0.00 | |
| J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg | 0% | 18 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 172 | $0.00 |
| 69200 | 0% | 54 | $0.00 | |
| 77003 | 0% | 16 | $0.00 | |
| 87254 | 0% | 18 | $0.00 | |
| 99354 | 0% | 29 | $0.00 | |
| 82610 | 0% | 13 | $0.00 | |
| 0141U | 0% | 14 | $0.00 | |
| A9999 | Miscellaneous dme supply or accessory, not otherwise specified | 0% | 12 | $0.00 |
| 82553 | 0% | 97 | $0.00 | |
| 82438 | 0% | 1,748 | $0.00 | |
| 80320 | 0% | 3,420 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 164 | $0.00 |
| 86664 | 0% | 81 | $0.00 | |
| 84478 | 0% | 13 | $0.00 | |
| 86355 | 0% | 1,640 | $0.00 | |
| 87015 | 0% | 110 | $0.00 | |
| 87184 | 0% | 154 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 714 | $0.00 |
| 83051 | 0% | 59 | $0.00 | |
| 86364 | 0% | 366 | $0.00 | |
| 88271 | 0% | 249 | $0.00 | |
| 80177 | 0% | 219 | $0.00 | |
| A4354 | Insertion tray with drainage bag but without catheter | 0% | 100 | $0.00 |
| 94761 | 0% | 282 | $0.00 | |
| 80329 | 0% | 2,769 | $0.00 | |
| 84157 | 0% | 577 | $0.00 | |
| J3360 | Injection, diazepam, up to 5 mg | 0% | 61 | $0.00 |
| 88275 | 0% | 243 | $0.00 | |
| 88311 | 0% | 338 | $0.00 | |
| 82040 | 0% | 64 | $0.00 | |
| 86769 | 0% | 166 | $0.00 | |
| 80180 | 0% | 248 | $0.00 | |
| 87206 | 0% | 110 | $0.00 | |
| 86160 | 0% | 126 | $0.00 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 340 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 62 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 241 | $0.00 |
| V5160 | Dispensing fee, binaural | 0% | 15 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 156 | $0.00 |
| 94760 | 0% | 374 | $0.00 | |
| 88291 | 0% | 20 | $0.00 | |
| 90673 | 0% | 1,533 | $0.00 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 0% | 81 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 29 | $0.00 |
| A4215 | Needle, sterile, any size, each | 0% | 62 | $0.00 |
| 87116 | 0% | 110 | $0.00 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 104 | $0.00 |
| 86225 | 0% | 29 | $0.00 | |
| 85335 | 0% | 12 | $0.00 | |
| 67515 | 0% | 14 | $0.00 | |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 41 | $0.00 |
| 90696 | 0% | 22 | $0.00 | |
| J9250 | Methotrexate sodium, 5 mg | 0% | 19 | $0.00 |
| 12013 | 0% | 26 | $0.00 | |
| 31622 | 0% | 31 | $0.00 | |
| 82607 | 0% | 14 | $0.00 | |
| 75825 | 0% | 36 | $0.00 | |
| 36011 | 0% | 13 | $0.00 | |
| J2794 | Injection, risperidone (risperdal consta), 0.5 mg | 0% | 199 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 12 | $0.00 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 0% | 12 | $0.00 |
| 86258 | 0% | 21 | $0.00 | |
| Q9968 | Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg | 0% | 14 | $0.00 |
| 86341 | 0% | 15 | $0.00 | |
| 84446 | 0% | 15 | $0.00 | |
| 10140 | 0% | 12 | $0.00 | |
| 77001 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFAROUGH, RAHEEL (SVP, MANAGED CARE & PAYOR STRATEGY)
| Provider | Location | Paid |
|---|---|---|
| Phoenix Children's Hospital | Phoenix, AZ | $162.37M |
| Phoenix Children's Hospital, INC. | Avondale, AZ | $3.96M |
| Phoenix Children's Hospital | Phoenix, AZ | $2.43M |
| Phoenix Children's Hospital, INC. | Mesa, AZ | $2.06M |
| Phoenix Children's Hospital, INC. | Glendale, AZ | $971K |
| Phoenix Children's Hospital, INC. | Scottsdale, AZ | $200K |
| Phoenix Children's Hospital, INC. | Phoenix, AZ | $51K |
| Phoenix Children's Hospital, INC. | Mesa, AZ | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.